| Accountable Care Organization 2013 Quality Performance Summary Statistics Report | |||||
| TP-ACO L.L.C. | |||||
| Domain | Measure Number | Measure Name | TP-ACO Performance Rate | Mean Performance Rate All ACOs | |
| Patient/Caregiver Experience | ACO-1 | Getting Timely Care, Appointments, and Information | 85.09 | 81.48 | |
| ACO-2 | How Well Your Doctors Communicate | 95.12 | 92.96 | ||
| ACO-3 | Patients’ Rating of Doctor | 93.37 | 92.06 | ||
| ACO-4 | Access to Specialists | 86.31 | 85.12 | ||
| ACO-5 | Health Promotion and Education | 61.91 | 58.38 | ||
| ACO-6 | Shared Decision Making | 75.91 | 75.43 | ||
| ACO-7 | Health Status/Functional Status | 69.98 | 71.12 | ||
| Care Coordination/Patient Safety | ACO-8 | Risk Standardized, All Condition Readmissions | 15.23 | 14.90 | |
| ACO-9 | ASC Admissions: COPD or Asthma in Older Adults | 1.55 | 1.17 | ||
| ACO-10 | ASC Admission: HF | 1.06 | 1.2 | ||
| ACO-11 | Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment | 54.90% | 66.21% | ||
| ACO-12 | Medication Reconciliation | 99.81% | 73.56% | ||
| ACO-13 | Falls: Screening for Fall Risk | 94.38% | 39.57% | ||
| Preventive Health | ACO-14 | Influenza Immunization | 50.35% | 56.93% | |
| ACO-15 | Pneumococcal Vaccination | 69.41% | 54.76% | ||
| ACO-16 | Adult Weight Screening and Follow-up | 95.69% | 61.61% | ||
| ACO-17 | Tobacco Use Assessment and Cessation Intervention | 99.52% | 84.01% | ||
| ACO-18 | Depression Screening | 97.56% | 31.19% | ||
| ACO-19 | Colorectal Cancer Screening | 80.58% | 59.30% | ||
| ACO-20 | Mammography Screening | 68.78% | 62.05% | ||
| ACO-21 | Proportion of Adults who had blood pressure screened in past 2 years | 98.80% | 74.25% | ||
| At Risk Population | Diabetes Composite | Beneficiaries with diabetes who met of all the following criteria: | 2.18% | 22.21% | |
| ACO-22 | Hemoglobin A1c Control (HbA1c) (<8 percent) | 48.30% | 68.58% | ||
| ACO-23 | Low Density Lipoprotein (LDL) (< 100 mg/dL) | 43.93% | 54.78% | ||
| ACO-24 | Blood Pressure (BP) < 140/90 | 47.09% | 69.53% | ||
| ACO-25 | Tobacco Non-Use | 8.25% | 63.33% | ||
| ACO-26 | Aspirin Use | 93.26% | 74.82% | ||
| ACO-27 | Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) | 44.66% | 22.11% | ||
| ACO-28 | Percent of beneficiaries with hypertension whose BP < 140/90 | 46.25% | 67.79% | ||
| ACO-29 | Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl | 46.99% | 55.44% | ||
| ACO-30 | Percent of beneficiaries who use Aspirin or other antithrombotic | 91.57% | 76.35% | ||
| ACO-31 | Beta-Blocker Therapy for LVSD | 99.00% | 79.82% | ||
| CAD Composite | Percent of beneficiaries with CAD who met all of the following criteria: | 89.83% | 62.78% | ||
| ACO-32 | Drug Therapy for Lowering LDL-Cholesterol | 90.56% | 71.60% | ||
| ACO-33 | (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) | 97.47% | 69.13% | ||